Shares of Evoke plc (LON:EVOK – Get Free Report) were down 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Ratings Changes
EVOK has been the topic of a number of analyst reports. Berenberg Bank reduced their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th.
Check Out Our Latest Research Report on EVOK
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, equities research analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is owned by corporate insiders.
Evoke Company Profile
Read More
- Five stocks we like better than Evoke
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 03/24 – 03/28
- What is the NASDAQ Stock Exchange?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is a Bond Market Holiday? How to Invest and Trade
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.